Which of the following drug is associated with highest cardiac moality?
**Core Concept**
The question is testing the student's knowledge of the cardiovascular side effects of various medications. The underlying pharmacological principle being tested is the potential of certain drugs to cause cardiac mortality.
**Why the Correct Answer is Right**
The correct answer is associated with cardiac mortality due to its potential to cause QT interval prolongation, leading to torsades de pointes and ventricular fibrillation. This is a result of its action on the hERG potassium channels in the cardiac tissue. The hERG channels are responsible for repolarization of the cardiac action potential. Prolongation of the QT interval increases the risk of arrhythmias and cardiac mortality.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while it can cause cardiac side effects, its mechanism of action is different from the one associated with the highest cardiac mortality.
**Option B:** This option is incorrect because it is not typically associated with cardiac mortality. It may have other side effects, but not to the extent of the correct answer.
**Option C:** This option is incorrect because it is not commonly linked to cardiac mortality. It may have other adverse effects, but not to the same degree as the correct answer.
**Clinical Pearl / High-Yield Fact**
It is essential to be aware of the potential for cardiac side effects when prescribing medications, especially those that can prolong the QT interval. The hERG potassium channels are a critical target in this context, and understanding their role in cardiac repolarization is crucial for safe prescribing practices.
**Correct Answer:** C. (Answer Text: **Dofetilide**)